Skip to main content
OpenTrials
Completed

NCT Number: NCT02846922

Catheter Ablation and Rate Control of Atrial Fibrillation in Patients With Heart Failure

To evaluate the efficacy of catheter ablation and rate control in heart failure patients with atrial fibrillation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Drum Tower Hospital

Nanjing, Jiangsu, 210008, China

About this study

All patients received either catheter ablation for rhythm control or rate control before enrollment, and the investigators do not assign specific interventions to the subjects during the study. So this study might be considered to be observational.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age>18 years
  • documented atrial fibrillation
  • New York Heart Association Ⅱ-Ⅳ or left ventricular ejection fraction <50%

Exclusion criteria

  • heart failure that had a suspected reversible cause
  • previous ablation
  • any contraindication to catheter ablation

Treatment and study plan

Primary outcomes

  1. Major adverse cardiac events

    Time frame: up to 3 years

    composite of all-cause mortality, stroke and unplanned hospitalization due to cardiovascular reasons

Secondary outcomes

  1. all-cause mortality

    Time frame: up to 3 years

  2. stroke

    Time frame: up to 3 years

    stroke must be certified by CT scan

  3. unplanned hospitalization due to cardiovascular reasons

    Time frame: up to 3 years

    Unplanned hospitalization will be present only if the patient is hospitalized unexpectedly because of persisting or increasing complaints of heart failure and ventricular arrhythmias

Sponsors and collaborators

Lead sponsor

Nanjing Medical University

Other

Registry information

Official study title

Catheter Ablation Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure: A Multicenter Study

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Jul 27, 2016
Registry last updated
Jul 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.